Evidence map›Paper›PMID 37606979›Full record

Observational studyJournal of medical Internet research2023

Adherence to Patient-Reported Symptom Monitoring and Subsequent Clinical Interventions for Patients With Multiple Myeloma in Outpatient Care: Longitudinal Observational Study.

Jens Lehmann, Kelly M de Ligt, Stefanie Tipelius, Johannes M Giesinger, Monika Sztankay, Sandra Voigt, Lonneke V van de Poll-Franse, Gerhard Rumpold, Roman Weger, Ella Willenbacher and 2 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05036863 (Feasibility Study of a Electronic Patient-Reported Outcome), which is not on this map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05036863 completednot on this map

Feasibility Study of a Electronic Patient-Reported Outcome (ePRO) Monitoring for Patients With Multiple Myeloma and Development and Evaluation of Treatment-specific Item Lists

TypeobservationalSponsorMedical University InnsbruckRan2021 to 2022Enrolled39ConditionsMultiple MyelomaArmsWeekly questionnaires
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Electronic patient-reported outcome platforms used in hematological cancers: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. A multi-dimensional assessment of fatigue among patients undergoing breast radiotherapy.Technical innovations & patient support in radiation oncology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Symptom experience of patients undergoing treatment for multiple myeloma: a longitudinal real-world electronic patient-reported outcomes study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  11. Observational
  12. Patient-reported symptom monitoring: using (big) data to improve supportive care at the macro-, meso-, and micro-levels.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jens LehmannUniversity Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-4670-7517
Kelly M de LigtDepartment of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, Netherlands.ORCID 0000-0001-9218-617X
Stefanie TipeliusSyndena GmbH, Innsbruck, Austria.ORCID 0009-0000-5285-8883
Johannes M GiesingerUniversity Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0003-2744-5950
Monika SztankayUniversity Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-7938-1250
Sandra VoigtSyndena GmbH, Innsbruck, Austria.ORCID 0009-0006-0268-4276
Lonneke V van de Poll-FranseDepartment of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, Netherlands.ORCID 0000-0003-0413-6872
Gerhard RumpoldUniversity Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-6037-793X
Roman WegerSyndena GmbH, Innsbruck, Austria.ORCID 0000-0003-3036-940X
Ella WillenbacherInternal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0003-2853-5405
Wolfgang WillenbacherSyndena GmbH, Innsbruck, Austria.ORCID 0000-0001-7702-1721
Bernhard HolznerUniversity Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-3389-3621

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of software to monitor patient-reported outcome measures (PROMs) can improve outcomes for patients with cancer receiving anticancer therapy; however, evidence from applications used in routine clinical practice is lacking.

objectiveWe aimed to investigate adherence to and patient perceptions of a weekly, web-based PROM symptom monitoring program in routine clinical practice for patients with Multiple Myeloma. Moreover, we aimed to capture how clinical alerts prompted by the system influenced clinical care.

methodsWe conducted a single-center longitudinal observational study to evaluate patient adherence to and perceptions of the PROM monitoring software in routine practice. Patients with Multiple Myeloma remotely completed weekly treatment-specific PROMs to monitor key symptoms via a dedicated web-based platform. Alarming symptoms triggered clinical alerts in the application for the treatment team, which could initiate clinical interventions. The primary outcomes were the web-based assessment completion rate and patients' perceptions of the monitoring program, as assessed by an evaluation questionnaire. Moreover, clinical alerts prompted by the system and consequential clinical interventions were analyzed.

resultsBetween July 2021 and June 2022, a total of 55 patients were approached for participation; 39 patients participated (24, 61% male, mean age 63.2, SD 9.2 years). The median assessment completion rate out of all weekly scheduled assessments was 70.3% (IQR 41.2%-89.6%). Most patients (77%) felt that the health care team was better informed about their health status due to the web-based assessments. Clinical alerts were triggered for 1758 of 14,639 (12%) reported symptoms. For 548 of 1758 (31.2%) alerts, the symptom had been registered before and no further action was required; for 348 of 1758 (19.9%) alerts, telephone consultation and self-management advice sufficed. Higher-level interventions were seldom needed in response to alerts: referral to a doctor or specialist (88/1758, 5% alerts), medication changes (22/1758, 1.3%), scheduling additional diagnostics (9/1758, 0.5%), or unplanned emergency visits (7/1758, 0.4%). Most patients (55%) reported the calls in response to alerts gave them "quite a bit" or "very much" of an added feeling of security during therapy.

conclusionsOur study shows that high adherence to regular and tailored PROM monitoring can be achieved in routine clinical care. The findings provide valuable insight into how the PROM monitoring program and the clinical alerts and resulting interventions shaped clinical practice.

trial registrationClinicalTrials.gov NCT05036863; https://clinicaltrials.gov/study/NCT05036863.

Indexed as

Multiple MyelomaAmbulatory CareFemaleHumansInternet-Based InterventionMaleMiddle AgedPatient Reported Outcome MeasuresQuality of LifeReferral and ConsultationTelephoneambulatory careapplicationcancer patientclinical caremonitoringmultiple myelomamyelomaneoplasmspatient-reported outcome measuresquality of lifesymptom monitoringsymptomstherapytreatmentweb-based assessment

Identifiers

PMID37606979
PMCPMC10481208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.